Checklist · Hemp · November 2026 Readiness

Hemp-Derived Cannabinoid Product Compliance Worksheet: November 2026 Readiness

Use this product-by-product worksheet to document Illinois Hemp Act readiness, labeling and packaging controls, laboratory support, inventory transition decisions, and a separate federal hemp analysis before the November 2026 transition.

By Lincoln Square Law · 8-minute read

🖨 Print this checklist

Use this checklist before the November 2026 Illinois transition

Illinois Public Act 104-0463 created the Illinois Hemp Act and set product, labeling, packaging, and other requirements that affect final consumer hemp cannabinoid products. Some provisions specifically reference November 12, 2026.

Federal hemp rules are also moving through a separate statutory transition. Treat the dates as two legal workstreams: identify what Illinois requires for the product sold in Illinois, then separately confirm the federal status of the same material and product.

This is a readiness worksheet, not a substitute for product-specific advice. Complete it for each SKU, formulation, container size, label, and distribution channel. Keep the supporting certificate of analysis, formulation record, label proof, supplier records, and written conclusion with the completed checklist.

Product-by-product readiness checklist

• Product identity: Identify the exact SKU, formulation, flavor, dosage form, container size, and intended consumer use.
• Cannabinoid source: Document each cannabinoid in the product and whether it is naturally produced by Cannabis sativa L. or synthesized or manufactured outside the plant.
• Total-THC calculation: Confirm the laboratory method and calculate total tetrahydrocannabinols for the entire retail container, not merely per serving.
• 0.4 mg container threshold: Determine whether the final consumer product exceeds the Illinois Act definition threshold of 0.4 mg total tetrahydrocannabinols per container.
• Certificate of analysis: Retain a batch-specific certificate of analysis and confirm it corresponds to the finished batch offered for sale.
• Label product name and quantity: Confirm the label states the product name and net weight or volume.
• Ingredient statement: Confirm the label contains a complete and accurate ingredient list in descending order of predominance.
• Cannabinoid disclosure: Confirm the label identifies the quantity of each cannabinoid present above the statutory reporting threshold, expressed as required per serving and per container.
• Serving information: Confirm the number of servings per container is stated and matches the formulation and package.
• Batch or lot number: Assign and display a batch or lot number that ties the consumer package to production and testing records.
• Manufacturer or distributor identity: Confirm the label contains the required name, business address, and contact information for the manufacturer or distributor.
• Expiration or use-by date: Confirm an expiration or use-by date is present and supported by the product-control process.
• QR code or web link: Confirm the label provides the required scannable code or website connection to the batch certificate of analysis.
• Child-resistant package: Confirm the sealed consumer container satisfies the child-resistant packaging requirement applicable under the Illinois Hemp Act.
• Marketing claims: Review claims, imagery, product names, and placement so the label and advertising do not imply a legal status or product characteristic that the records do not support.
• Federal classification: Separately document the product analysis under the federal hemp definition and the 2026 federal transition. Do not treat Illinois compliance as proof of federal compliance.
• Inventory transition: Identify existing inventory that may not meet the new Illinois requirements and assign a written disposition plan before the applicable transition date.
• Vendor certifications: Collect supplier specifications, testing records, and written representations for ingredients and cannabinoid inputs. Verify rather than relying on marketing descriptions.
• Retail and distributor instructions: Give downstream partners the approved SKU list, label version, storage requirements, stop-sale instructions, and contact for compliance questions.
• Change control: Require re-review before changing formulation, cannabinoid source, container size, serving size, label, manufacturer, testing laboratory, or material marketing claim.

Do not collapse state and federal analysis into one number

The Illinois Act’s product definitions and labeling rules must be read as enacted. Federal hemp law uses its own statutory definitions and transition provisions. A product team should therefore keep a two-column legal analysis: Illinois product eligibility and federal classification. The same laboratory result may be relevant to both columns, but the legal test and effective date may differ.

For any product near a threshold, retain the laboratory method, uncertainty information where provided, sample identity, batch identity, and calculation used to reach the legal conclusion. A spreadsheet that simply says “pass” is not enough if the underlying test or container calculation cannot be reconstructed.

Freeze approved labels and formulations

Once a SKU passes review, freeze the approved formulation, container, serving size, label file, and certificate-of-analysis workflow. Production should not substitute a cannabinoid ingredient, resize the package, change the number of servings, or revise a claim without routing the change back through compliance review. That change-control step prevents a product that was compliant when approved from drifting into a different legal category.

The same control should apply to websites, distributor catalogs, point-of-sale descriptions, and marketplace listings. A compliant physical label can be undermined by a digital description that promises a different dosage, cannabinoid profile, or intended effect. Keep the approved product description with the label package and distribute one controlled version to sales partners.

Document the transition decision for old inventory

The most difficult implementation question is often existing inventory. Before the applicable effective date, identify finished products, work in process, packaging already printed, raw cannabinoid inputs, and distributor inventory that could be affected. Assign a disposition decision to each category: continue selling through a lawful period, relabel where legally permitted, reformulate, return, destroy, or otherwise remove from the Illinois consumer channel.

Do not make that decision from a calendar reminder alone. Confirm the operative statutory text, any implementing rules or agency instructions then in effect, and the actual product facts. Because this worksheet is prepared before November 2026, the final launch review should confirm whether any rulemaking or official guidance changes the operational details before the transition date.

Keep a defensible product file

For each approved SKU, retain the enacted-law analysis, ingredient specifications, supplier documents, formulation, batch record, certificate of analysis, label proof, packaging specification, child-resistance support, QR destination, marketing copy, approval date, reviewer, and any later change-control record. The file should make it possible to answer three questions quickly: what was sold, what evidence supported the legal classification, and which label and package accompanied that product.

A disciplined product file also makes recalls and stop-sale decisions faster. If a test, supplier, statute, or agency instruction changes, the company can identify the affected SKUs and batches without rebuilding the history from email.

That is the practical value of completing the checklist before launch rather than after a regulator, distributor, or retailer raises a question.

Assign a named owner to every readiness item

A checklist is useful only if each line has an accountable person and evidence of completion. Regulatory should own the legal classification and final approval. Quality should own testing and batch traceability. Packaging or marketing should control label artwork and claims. Operations should control formulation and change management. Sales should distribute only approved product descriptions. Assign a completion date and evidence link for each item so management can distinguish a finished requirement from a verbal assurance.

Before launch, conduct a cross-functional release meeting for each affected product family. Compare the approved formulation, laboratory result, container count, label proof, QR destination, supplier records, and inventory status side by side. Record any exceptions and prohibit shipment until the exception is resolved or a documented legal conclusion permits release. Repeat that review when a supplier, formulation, package size, statutory requirement, or official agency instruction changes.

Prepare a stop-sale and recall decision tree

The readiness file should identify who can stop sale, who contacts distributors and retailers, how affected lots are identified, and what records support disposition. A change in law, failed or inconsistent test, incorrect label, supplier issue, or packaging defect can require immediate containment even before the company determines the final remedy. A predefined decision tree reduces delay and prevents different channels from continuing to sell a product while the legal and quality teams are still investigating.